Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5

FEBS Lett. 2023 Dec;597(24):3049-3060. doi: 10.1002/1873-3468.14778. Epub 2023 Dec 6.

Abstract

Inflammatory chemokines are often elevated in disease settings, where the largest group of CC-chemokines are the macrophage inflammatory proteins (MIP), which are promiscuous for the receptors CCR1 and CCR5. MIP chemokines, such as CCL3 and CCL5 are processed at the N terminus, which influences signaling in a highly diverse manner. Here, we investigate the signaling capacity of peptides corresponding to truncated N termini. These 3-10-residue peptides displayed weak potency but, surprisingly, retained their signaling on CCR1. In contrast, none of the peptides generated a signal on CCR5, but a CCL3-derived tetrapeptide was a positive modulator boosting the signal of several chemokine variants on CCR5. In conclusion, chemokine N termini can be mimicked to produce small CCR1-selective agonists, as well as CCR5-selective modulators.

Keywords: GPCR; allosteric modulation; chemokine; chemokine truncation; pharmacology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemokine CCL3
  • Chemokine CCL4
  • Chemokines* / metabolism
  • Chemokines* / pharmacology
  • Macrophage Inflammatory Proteins / chemistry
  • Macrophage Inflammatory Proteins / metabolism
  • Receptors, Chemokine* / agonists
  • Receptors, Chemokine* / metabolism

Substances

  • Chemokine CCL3
  • Chemokine CCL4
  • Receptors, Chemokine
  • Chemokines
  • Macrophage Inflammatory Proteins